Scottsdale TMS Therapy has introduced FDA-approved Spravato (esketamine) nasal spray treatments, expanding access for adults in the Southwest to a fast-acting option that can reduce depressive symptoms within days. This addition broadens the clinic's interventional psychiatry services, offering a meaningful alternative for patients who have not responded to two or more standard antidepressant trials.
Conventional oral antidepressants often take four to six weeks to work and may produce limited results for persistent mood disorders. Spravato operates through a distinct mechanism, acting on NMDA receptors to promote neuroplasticity, the brain's ability to form new neural connections. According to a clinic spokesperson, when standard medications fail, it indicates that different neural stimulation is needed, and Spravato serves as an immediate lifeline that restores cognitive flexibility.
As a tightly regulated medication, esketamine requires structured administration. Scottsdale TMS Therapy is a fully REMS-certified clinic, meeting all federal safety standards. Each session includes pre-treatment health screenings, supervised self-administration, and a two-hour post-treatment observation period with continuous vital sign monitoring. This care is provided in a comfort-focused setting with Apollo TMS chairs, private rooms, an on-site cafe, and an outdoor patio.
The clinic works with major commercial insurers and manages the full authorization process. For more information, visit Scottsdale TMS Therapy.
